Clinical trial
Bupropion for the Treatment of Methamphetamine Dependence
NCT00069251 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bupropion for the Treatment of Methamphetamine Dependence
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- June 30, 2005
- Enrollment
- 150
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.